​
​

InterCure (INCR) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

InterCure Revenue Highlights

Latest Revenue (Y)

$355.55M

Latest Revenue (Q)

$73.47M

InterCure Revenue by Period

InterCure Revenue by Year

DateRevenueChange
2023-12-31--8.52%
2022-12-31-76.93%
2021-12-31-237.78%
2020-12-31-628.60%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--100.00%
2015-12-31--75.20%
2014-12-31--31.51%
2013-12-31--2.59%
2012-12-31--29.82%
2011-12-31--8.76%
2010-12-31--

InterCure generated $355.55M in revenue during NA 2023, up -8.52% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

InterCure Revenue by Quarter

DateRevenueChange
2023-12-31--
2023-09-30--28.28%
2023-06-30--3.52%
2023-03-31-0.54%
2022-12-31-5.01%
2022-09-30-5.56%
2022-06-30-9.23%
2022-03-31-9.45%
2021-12-31-29.19%
2021-09-30-36.40%
2021-06-30-36.85%
2021-03-31-21.99%
2020-12-31-20.43%
2020-09-30-101.14%
2020-06-30-162.62%
2020-03-31-132.99%
2019-12-31--29.64%
2019-09-30--6.45%
2019-06-30-61.17%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--100.00%
2015-12-31--85.09%
2015-09-30--26.98%
2015-06-30--16.24%
2015-03-31--46.90%
2014-12-31--2.77%
2014-09-30--18.91%
2014-06-30--36.54%
2014-03-31--11.94%
2013-12-31-38.32%
2013-09-30--9.64%
2013-06-30--24.04%
2013-03-31-30.56%
2012-12-31-2.16%
2012-09-30--15.73%
2012-06-30--8.71%
2012-03-31--20.59%
2011-12-31--
2011-09-30--
2011-06-30--
2011-03-31--8.76%
2010-12-31--
2010-09-30--
2010-06-30--
2010-03-31--

InterCure generated $73.47M in revenue during Q4 2023, up 0.00% compared to the previous quarter, and up 73.05% compared to the same period a year ago.

InterCure Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PBHPrestige Consumer Healthcare--
PAHCPhibro Animal Health--
PCRXPacira BioSciences--
COLLCollegium Pharmaceutical--
INCRInterCure--
EGRXEagle Pharmaceuticals--
SSICSilver Spike Investment--
IXHLIncannex Healthcare--
RGCRegencell Bioscience--

INCR Revenue FAQ

What is InterCure’s yearly revenue?

InterCure's yearly revenue for 2023 was $355.55M, representing a decrease of -8.52% compared to 2022. The company's yearly revenue for 2022 was $388.68M, representing an increase of 76.93% compared to 2021. INCR's yearly revenue for 2021 was $219.68M, representing an increase of 237.78% compared to 2020.

What is InterCure’s quarterly revenue?

InterCure's quarterly revenue for Q4 2023 was $73.47M, a 0% increase from the previous quarter (Q3 2023), and a -30.43% decrease year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $73.47M, a -28.28% decrease from the previous quarter (Q2 2023), and a -26.95% decrease year-over-year (Q3 2022). INCR's quarterly revenue for Q2 2023 was $102.44M, a -3.52% decrease from the previous quarter (Q1 2023), and a 7.52% increase year-over-year (Q2 2022).

What is InterCure’s revenue growth rate?

InterCure's revenue growth rate for the last 3 years (2021-2023) was 61.85%, and for the last 5 years (2019-2023) was 3883.34%.